Mengdan Yan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Telomeres, Telomerase, and Senescence
Papers in
-
- RNA modifications and cancer 5
- Genetics 8
- Genetic Associations and Epidemiology 4
- Genetics and Neurodevelopmental Disorders 2
- Glioma Diagnosis and Treatment 2
- High Altitude and Hypoxia 2
- Co-authors
- Jingjie Li (9 shared papers)Fanglin Niu (11 shared papers)Tianbo Jin (10 shared papers)Tianbo Jin (8 shared papers)Tianbo Jin (6 shared papers)Jing Li (1 shared paper)Xianhua Chen (1 shared paper)Dongya Yuan (5 shared papers)
- Journals
- Oncotarget (18 papers)Medicine (6 papers)The Journal of Gene Medicine (2 papers)BMC Medical Education (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Mengdan Yan
41 papers receiving 353 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 67
- Physiology 47
- Pathology and Forensic Medicine 29
- Pharmacology 15
- Aging 3
Countries citing papers authored by Mengdan Yan
This map shows the geographic impact of Mengdan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdan Yan more than expected).
Fields of papers citing papers by Mengdan Yan
This network shows the impact of papers produced by Mengdan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdan Yan. The network helps show where Mengdan Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengdan Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 22 | |
| 2 | 2016 | 18 | |
| 3 | MiR-100-5p, miR-199a-3p and miR-199b-5p induce autophagic death of endometrial carcinoma cell through targeting mTOR. | 2017 | 14 |
| 4 | 2017 | 14 | |
| 5 | 2017 | 14 | |
| 6 | 2017 | 14 | |
| 7 | 2017 | 14 | |
| 8 | 2019 | 13 | |
| 9 | 2016 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2017 | 12 | |
| 12 | 2016 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2016 | 10 | |
| 16 | 2016 | 10 | |
| 17 | 2017 | 10 | |
| 18 | 2018 | 9 | |
| 19 | 2016 | 9 | |
| 20 | 2017 | 9 |
About Mengdan Yan
Mengdan Yan is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Physiology, having authored 41 papers that have together received 356 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Genetic Associations and Epidemiology (4 papers), Cancer-related molecular mechanisms research (4 papers), Genetics and Neurodevelopmental Disorders (2 papers), Glioma Diagnosis and Treatment (2 papers) and High Altitude and Hypoxia (2 papers). The work is most often cited by research in Cancer Research (67 citations), Physiology (47 citations), Pathology and Forensic Medicine (29 citations), Pharmacology (15 citations) and Aging (3 citations). Mengdan Yan has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jingjie Li, Fanglin Niu, Tianbo Jin, Tianbo Jin, Tianbo Jin, Jing Li, Xianhua Chen, Dongya Yuan, Yifeng Yang and Xiyang Zhang. Their work appears in journals such as Oncotarget, Medicine, The Journal of Gene Medicine, BMC Medical Education and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.